Physician profile
Brett W Davies
NPI 1497959746
$4,568.58
in general payments reported to CMS, 2019-2025
12 companies · $874 in 2025
The $874 reported for 2025 was more than what 75% of Ophthalmic Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $299).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201 · 2020: $103 · 2021: $338 · 2022: $1,817 · 2023: $443 · 2024: $793 · 2025: $874.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,110.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $2,462.10 | 2019-2025 | |
| Amgen INC. | $450.81 | 2024-2025 | Tepezza |
| Horizon Therapeutics Plc | $414.90 | 2019-2023 | Tepezza |
| Sight Sciences, INC. | $265.08 | 2020-2024 | Omni Surgical System |
| Stryker Corporation | $250.24 | 2024-2025 | Na |
| Alcon Vision LLC | $174.97 | 2021-2025 | Centurion |
| Bausch & Lomb Americas INC. | $144.60 | 2024 | Vyzulta, Miebo, Xiidra |
| Genentech USA, INC. | $138.05 | 2021 | |
| Quidel Corporation | $134.93 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $60.86 | 2019-2022 | |
| Rxsight INC | $58.85 | 2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $13.19 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett Davies listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.